Search Results
Facet (Page)
Refine Your Search
Audiences
Content Formats
Events
Sections
Divisions
Programs
- Developmental Genotype-Tissue Expression (dGTEx)1
- Genome Technology Program2
- Impact of Genomic Variation on Function (IGVF) Consortium3
- Clinical Genome (ClinGen) Resource1
- Polygenic RIsk MEthods in Diverse populations (PRIMED) Consortium1
- Genomics Research to Elucidate the Genetics of Rare Diseases (GREGOR) Consortium1
The Genomics Landscape
In the April 2019 edition of The Genomics Landscape, NHGRI Director Eric Green previews the redesigned genome.gov website and its new features.
… Lung, and Blood Institute, who is working to develop a gene therapy-based treatment for sickle cell disease. This … Alcohol Use and Adult Anxiety  Largest-Ever Alzheimer's Gene Study Brings New Answers  Mood-Altering Messenger Goes … Tic-Tac-Toe Game Built from DNA Researchers Uncover Gene Regions that Affect Cholesterol Levels in Smokers …
The Genomics Landscape
In the October 2023 edition of The Genomics Landscape, NHGRI Director Eric Green, reflects on the twelve years of groundbreaking research by the Clinical Sequencing Evidence-generating Research (CSER) consortium.
… and her research group identified mutations in the GBA1 gene as a risk factor for Parkinson’s disease by uncovering … Gaucher disease, which is caused by mutations in the same gene. The discovery of GBA1 mutations as a risk factor for … group that aimed to understand genome function and gene pathways in development and disease. His group was the …
About NHGRI
A timeline of notable events in the history of the National Human Genome Research Institute.
… and other researchers identify the location of the first gene associated with Parkinson's disease. November 1996: … other researchers identify the location of the first major gene that predisposes men to prostate cancer. December 1996: … of Health announce awards to support the Genotype-Tissue Expression (GTEx) project , an initiative to understand how …
News Release
NHGRI researchers will present four platform talks and 55 posters to highlight the institute's diverse portfolio at the 65th annual meeting of ASHG.
… Mutations in human homologue of chicken talpid-3 gene ( KIAA0586 ) cause a hybrid ciliopathy with overlapping … 11:00 - 12:00 p.m. 489T. Randy J. Chandler: Promoterless gene-targeting using adenoassociated viral (AAV)-mediated … and Dysmorphology) *2803F. Marjorie Lindhurst: Ubiquitous expression of the Proteus mutation Akt1 c. 49G>A, p. …
The Genomics Landscape
In the July 2020 edition of The Genomics Landscape, NHGRI Director Eric Green recalls the White House event announcing the draft human genome sequence.
… one that covered about 99 percent of the genome's gene-containing regions and had an accuracy of 99.99 percent. … Coordinating Center for the Developmental Genotype-Tissue Expression Project Pediatric Biospecimen Procurement Center (BPC) supporting the Developmental Gene Expression (dGTEx) Project Advancing Genomic Medicine …
Research at NHGRI
The Technology Transfer Office is responsible for transferring NHGRI technologies to the private sector and exchanging research materials with outside groups.
Policies and Guidance
Text, graphics, videos, illustrations and other information on NHGRI websites are in the public domain, unless indicated.
Policies and Guidance
NHGRI encourages you to share your thoughts on the topics explored on genome.gov and other websites we own or administer.
The Genomics Landscape
In the February 2024 issue of The Genomics Landscape, NHGRI Director Eric Green spotlights the Genome Statute and Legislation Database, which recently received a major revamp to help researchers, policy analysts, and the public more easily find state-level legislation related to genomics.
… into the many ways that people vary in their risk for and expression of diseases and traits. The presentations and …
The Genomics Landscape
In the July 7, 2022 edition of The Genomics Landscape, NHGRI Director, Eric Green, M.D., Ph.D., emphasizes the importance of the Technology Transfer Office and its mission to manage all the legal negotiations that help to protect federally funded research from being unduly exploited, while also giving that research avenues to reach patients through the commercialization of promising advances.
… with her then-boss Richard Maraia in studying a gene on human chromosome 7. This led to a publication on … the commercialization of promising advances, such as gene therapies, pharmaceutical drugs, novel technologies, … search by scientific area. … Genomics Research Gene therapy for rare eye disease safe but lacks efficacy in …